We estimated the standardized mortality ratio by comparing with the general population.

Conclusion: Comparing the two surveys, the standardized mortality of cancers was increased.

Mortality rates were compared using age-adjusted standardized mortality ratios and person-time techniques.

Standardized mortality and incidence ratios were calculated using national reference data.

There was no clear pattern of risk- standardized mortality rates across quartiles.

It is speculated that the age- standardized mortality will decrease in the near future.

Standardized mortality charts showed that Negroes died at an earlier age than whites.

Age- and mortality-adjusted rates of in-hospital mortality and standardized mortality ratios were calculated for four time periods.

Conclusions: ICU admission rates for HF varied markedly across hospitals and lacked association with in-hospital risk- standardized mortality.

This was compared with the standardized mortality ratio, an index of the overall performance of the unit.

In all causes of death, except tumours and trauma, decreasing standardized mortality ratios over time were seen.

Conclusions: We observed a strong heterogeneity of standardized mortality rates across all countries analyzed for 6 autoimmune diseases.

Standardized mortality ratios were calculated for specific causes of death on the basis of national and regional reference rates.

Survival was compared with the expected survival in the general age- and sex-matched population, and standardized mortality rates were calculated.

OS was compared with age- and sex-matched general Chinese population using expected survival and standardized mortality ratio (SMR).

The mean risk- standardized mortality rate was 8.6% and ranged from 5.9% to 13.5%.